WuXi Biologics Named to A List for CDP Supplier Engagement Assessment
WuXi Biologics (WXXWY), a global Contract Research, Development, and Manufacturing Organization (CRDMO), has been named to CDP's A List for Supplier Engagement Assessment (SEA), recognizing its leadership in supply chain climate engagement. The company achieved superior performance in supplier climate engagement across governance, business strategy, targets, and Scope 3 emissions reporting.
The company has demonstrated significant environmental progress, achieving a 30% reduction in GHG emissions intensity (Scope 1 and 2) in 2024 compared to 2020, with a commitment to achieve net-zero emissions by 2050. WuXi Biologics has also maintained its position on CDP's Water Security A List and received Climate Change Leadership-level scores for two consecutive years.
WuXi Biologics (WXXWY), un'organizzazione globale di Ricerca, Sviluppo e Produzione a Contratto (CRDMO), è stata inserita nella Lista A di CDP per la Valutazione dell'Impegno dei Fornitori (SEA), riconoscendo la sua leadership nell'impegno climatico della catena di approvvigionamento. L'azienda ha ottenuto risultati eccellenti nell'impegno climatico dei fornitori in ambiti quali governance, strategia aziendale, obiettivi e rendicontazione delle emissioni Scope 3.
WuXi Biologics ha dimostrato significativi progressi ambientali, raggiungendo una riduzione del 30% dell'intensità delle emissioni di gas serra (Scope 1 e 2) nel 2024 rispetto al 2020, con l'impegno di raggiungere emissioni nette zero entro il 2050. Inoltre, l'azienda ha mantenuto la sua posizione nella Lista A per la Sicurezza Idrica di CDP e ha ottenuto punteggi di Leadership per il Cambiamento Climatico per due anni consecutivi.
WuXi Biologics (WXXWY), una organización global de Investigación, Desarrollo y Fabricación por Contrato (CRDMO), ha sido incluida en la Lista A de CDP para la Evaluación del Compromiso del Proveedor (SEA), reconociendo su liderazgo en el compromiso climático en la cadena de suministro. La compañía logró un desempeño sobresaliente en el compromiso climático de proveedores en gobernanza, estrategia empresarial, objetivos e informes de emisiones de Alcance 3.
La empresa ha demostrado un progreso ambiental significativo, logrando una reducción del 30% en la intensidad de emisiones de GEI (Alcance 1 y 2) en 2024 en comparación con 2020, con el compromiso de alcanzar emisiones netas cero para 2050. WuXi Biologics también ha mantenido su posición en la Lista A de Seguridad Hídrica de CDP y ha recibido puntuaciones de liderazgo en Cambio Climático durante dos años consecutivos.
WuXi Biologics (WXXWY)는 글로벌 계약 연구, 개발 및 제조 조직(CRDMO)으로서, 공급망 기후 참여 부문에서의 리더십을 인정받아 CDP의 공급업체 참여 평가(SEA) A 리스트에 선정되었습니다. 이 회사는 거버넌스, 비즈니스 전략, 목표 설정, Scope 3 배출 보고 등 공급업체 기후 참여에서 우수한 성과를 거두었습니다.
WuXi Biologics는 2020년 대비 2024년에 온실가스 배출 강도(Scope 1 및 2)를 30% 감축하는 등 환경적 진전을 이루었으며, 2050년까지 넷제로 배출을 달성하겠다는 약속을 했습니다. 또한, CDP의 물 안보 A 리스트에 계속 이름을 올렸고, 기후 변화 리더십 수준 점수를 2년 연속 획득했습니다.
WuXi Biologics (WXXWY), une organisation mondiale de Recherche, Développement et Fabrication sous contrat (CRDMO), a été inscrite sur la Liste A de CDP pour l'Évaluation de l'Engagement des Fournisseurs (SEA), reconnaissant son leadership dans l'engagement climatique de la chaîne d'approvisionnement. L'entreprise a obtenu une performance supérieure dans l'engagement climatique des fournisseurs en matière de gouvernance, stratégie commerciale, objectifs et rapport sur les émissions de Scope 3.
L'entreprise a réalisé des progrès environnementaux significatifs, atteignant une réduction de 30 % de l'intensité des émissions de GES (Scope 1 et 2) en 2024 par rapport à 2020, avec un engagement à atteindre la neutralité carbone d'ici 2050. WuXi Biologics a également maintenu sa position sur la Liste A de la Sécurité de l'Eau de CDP et a obtenu des scores de leadership en matière de changement climatique pendant deux années consécutives.
WuXi Biologics (WXXWY), ein globales Contract Research, Development und Manufacturing Organization (CRDMO), wurde in die A-Liste von CDP für die Bewertung des Lieferantenengagements (SEA) aufgenommen, was seine Führungsrolle im Bereich Klimabewusstsein in der Lieferkette anerkennt. Das Unternehmen erzielte herausragende Leistungen beim Engagement der Lieferanten in den Bereichen Governance, Geschäftsstrategie, Zielsetzungen und Berichterstattung der Scope-3-Emissionen.
Das Unternehmen hat bedeutende ökologische Fortschritte erzielt, indem es die THG-Emissionsintensität (Scope 1 und 2) im Jahr 2024 im Vergleich zu 2020 um 30 % reduziert hat und sich verpflichtet, bis 2050 Netto-Null-Emissionen zu erreichen. WuXi Biologics hält zudem seine Position auf der CDP-Wassersicherheits-A-Liste und erhielt zwei Jahre in Folge Bewertungsergebnisse auf Führungsebene im Bereich Klimawandel.
- Achieved 30% reduction in GHG emissions intensity from 2020 to 2024
- Received multiple prestigious ESG recognitions including MSCI AAA Rating and EcoVadis Platinum Medal
- Named to CDP's A List for both Supplier Engagement and Water Security
- None.
- Earns CDP's highest rating for supply chain engagement on climate
- Adds to other CDP recognition—Water Security A List and leadership score on climate change
- Drives sustainability through value chain decarbonization empowerment
CDP is recognized as the global standard for corporate environmental reporting, and its annual ratings are widely used to drive investment and procurement decisions. In 2024, nearly 25,000 companies—representing two-thirds of the global market value—reported environmental data through CDP. WuXi Biologics was named to the CDP's SEA A List for superior performance regarding supplier climate engagement in terms of governance and business strategy, targets, Scope 3 emissions reporting, and risk management process. The company has also been included in CDP's Water Security A List and has received Climate Change Leadership-level scores from the organization for two consecutive years.
Committed to the Science Based Target initiative (SBTi), WuXi Biologics has adopted an integrated strategy to tackle climate change with measurable targets and a refined roadmap. The company realized a
Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, "We are very pleased to be named to the CDP's A List for its Supplier Engagement Assessment, an acknowledgement that further inspires our steadfast dedication to driving sustainability. As a global leader in Green CRDMO, we consistently deliver ESG excellence, enable partners worldwide with end-to-end solutions, and work together with all stakeholders to promote responsible practices."
As a participant of the United Nations Global Compact (UNGC) and Pharmaceutical Supply Chain Initiative (PSCI), WuXi Biologics proactively advocates sustainability and has earned widespread recognitions for its efforts. The company was granted an MSCI AAA Rating; awarded an EcoVadis Platinum Medal; listed in the Dow Jones Sustainability Indices (DJSI); named to the CDP Water Security "A List" and awarded an A- CDP Climate Change leadership-level score for two consecutive years; given the highest negligible-risk rating by Sustainalytics, and recognized as a Sustainalytics industry and regional ESG top-rated company for five consecutive years; selected as a Constituent of the FTSE4Good Index Series; listed in the Hang Seng ESG 50 Index; and rated as Prime by ISS ESG Corporate Rating.
About CDP
CDP is a global non-profit that runs the world's only independent environmental disclosure system. As the founder of environmental reporting, the organization believes in transparency and the power of data to drive change. Partnering with leaders in enterprise, capital, policy and science, CDP surfaces the information needed to enable Earth-positive decisions. It helped more than 24,800 companies and 1,100 cities, states and regions disclose their environmental impacts in 2024. Financial institutions with more than a quarter of the world's institutional assets use CDP data to help inform investment and lending decisions. Aligned with the ISSB's climate standard, IFRS S2, as its foundational baseline, CDP integrates best-practice reporting standards and frameworks in one place. The team is truly global, united by a shared desire to build a world where people, planet and profit are truly balanced.
About WuXi Biologics
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.
With over 12,000 skilled employees in
WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives green technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while consistently achieving excellence in Environment, Social and Governance (ESG). Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts and promote responsible practices that empower the entire value chain.
For more information about WuXi Biologics, please visit: www.wuxibiologics.com.
View original content:https://www.prnewswire.com/news-releases/wuxi-biologics-named-to-a-list-for-cdp-supplier-engagement-assessment-302523000.html
SOURCE WuXi Biologics
FAQ
What ESG achievements did WuXi Biologics (WXXWY) receive in 2025?
What are WuXi Biologics' greenhouse gas emission reduction targets?
What environmental initiatives is WuXi Biologics participating in?
How does WuXi Biologics engage with its suppliers on climate issues?
